Modulation of immunity and host resistance by micro-organisms

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Pharmacology & Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0163-7258(80)90059-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of immunity by macrophages

  1985cited by this paper
• Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells.

  1978cited by this paper
• Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages

  1978cited by this paper
• Recognition and destruction of target cells by tumoricidal macrophages.

  1978cited by this paper
• Suppression of rat T cell proliferation by Corynebacterium parvum: T cell requirement for induction.

  1978cited by this paper
• Activated macrophages kill tumour cells by releasing arginase

  1978cited by this paper
• Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity

  1978cited by this paper
• Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the LPS gene.

  1978cited by this paper
• BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

  1978cited by this paper
• Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.

  1978cited by this paper
• Mechanisms by which Activated Macrophages Inhibit Lymphocyte Responses

  1978cited by this paper
• Cloned macrophages can be induced to kill tumor cells.

  1978cited by this paper
• Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.

  1978cited by this paper
• Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.

  1978cited by this paper
• Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas

  1977cited by this paper
• Synergistic infection with murine cytomegalovirus and Candida albicans in mice.

  1977cited by this paper
• THE BIOREGULATORY PROPERTIES OF SERUM LOW DENSITY LIPOPROTEIN INHIBITOR (LDL-IN) ON THE GENERATION OF KILLER T CELLS

  1977cited by this paper
• Synthesis and release of thymidine by macrophages.

  1977cited by this paper
• The immunosuppressive effect of type II mouse interferon preparations on antibody production.

  1977cited by this paper
• Macrophage regulation of mitogen-induced blastogenesis. I. Demonstration of inhibitory cells in the spleens and peritoneal exudates of mice.

  1977cited by this paper
• Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins

  1977cited by this paper
• Macrophages synthesise and release prostaglandins in response to inflammatory stimuli

  1977cited by this paper
• Studies on immune responses to larval cestodes in mice: a simple mechanism of non-specific immunosuppression in Mesocestoides corti-infected mice.

  1977cited by this paper
• Macrophage tumor killing: influence of the local environment.

  1977cited by this paper
• Effect of in vivo stimulation of mice on the secretion of factor B of the alternative complement pathway by peritoneal macrophages

  1977cited by this paper
• Immunosuppression in murine malaria. II. The primary response to bovine serum albumin.

  1977cited by this paper
• Prostaglandin-producing suppressor cells in Hodgkin's disease.

  1977cited by this paper
• Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.

  1977cited by this paper
• Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins

  1977cited by this paper
• Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors

  1977cited by this paper
• Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation.

  1977cited by this paper
• Immunosuppression in murine malaria. I. Response to type III pneumococcal polysaccharide.

  1977cited by this paper
• Suppression of in vitro cytotoxic response by macrophages due to induced arginase

  1977cited by this paper
• Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition

  1977cited by this paper
• The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977.

  1977cited by this paper
• Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.

  1977cited by this paper
• Macrophage regulation of mitogen-induced blastogenesis. II. Mechanism of inhibition.

  1977cited by this paper
• Immune interferon I. Production by lymphokine‐activated murine macrophages

  1977cited by this paper
• Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

  1977cited by this paper
• Production of the second component of complement by human monocytes: stimulation by antigen-activated lymphocytes or lymphokines

  1977cited by this paper
• Biosynthesis of pro-C3, a precursor of the third component of complement

  1977cited by this paper
• Interferon: an inducer of macrophage activation by polyanions.

  1977cited by this paper
• Suppressor cells in mice infected with Trypanosoma brucei.

  1977cited by this paper
• Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.

  1977cited by this paper
• Effect of human monocytes and macrophages on Trypanosoma cruzi.

  1977cited by this paper
• In vivo suppression of the primary immune response by a species of low density serum lipoprotein.

  1977cited by this paper
• Studies on the regulation of lymphocyte reactivity by normal and activated macrophages.

  1977cited by this paper
• Immunodepression in Babesia microti infections

  1977cited by this paper
• Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

  1976cited by this paper
• Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.

  1976cited by this paper
• Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections

  1976cited by this paper
• Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

  1976cited by this paper
• Protection of mice against Babesia, and Plasmodium with BCG

  1976cited by this paper
• Cytolytic effects of the complement cleavage product, C3a.

  1976cited by this paper
• Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A

  1976cited by this paper
• Modulation of the immune response by BCG: a review.

  1976cited by this paper
• Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii

  1976cited by this paper
• Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.

  1976cited by this paper
• Control of lymphokine secretion by prostaglandins

  1976cited by this paper
• 9 – Nonspecific Immunoregulation by Macrophages and Their Products

  1976cited by this paper
• Role of activated macrophages in resistance of mice to infection with Trypanosoma cruzi.

  1976cited by this paper
• Inhibition of lymphoproliferation by hyperlipoproteinemic plasma.

  1976cited by this paper
• Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

  1976cited by this paper
• Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.

  1976cited by this paper
• Interaction of BCG-activated macrophages with neoplastic and noneoplastic cell lines in vitro: cinemicrographic analysis.

  1975cited by this paper
• Macrophage activation by lymphocyte mediators.

  1975cited by this paper
• Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.

  1975cited by this paper
• Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum.

  1975cited by this paper
• Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.

  1975cited by this paper
• Activation of lymphoid cells by BCG in vitro.

  1975cited by this paper
• Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells.

  1975cited by this paper
• Immunoadjuvant activity of pyran copolymer. I. Evidence for direct stimulation of T-lymphocytes and macrophages.

  1975cited by this paper
• Defect of macrophage function in the antibody response to sheep erythrocytes in systemic Mycobacterium lepraemurium infection

  1975cited by this paper
• Macrophages on intrauterine contraceptive devices produce prostaglandins

  1975cited by this paper
• Regional immunosuppression induced by Plasmodium berghei yoelii infection in mice

  1975cited by this paper
• Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

  1975cited by this paper
• Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages.

  1975cited by this paper
• Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.

  1975cited by this paper
• Biochemical characterization of a factor released by macrophages.

  1975cited by this paper
• Activated macrophages as cytotoxic effector cells. II. Requirement for local persistence of inducing antigen.

  1975cited by this paper
• Major changes in lymphocyte proliferation evoked by activated macrophages.

  1975cited by this paper
• Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

  1975cited by this paper
• Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.

  1974cited by this paper
• Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum.

  1974cited by this paper
• Inhibition of the immune response to pertussis vaccine during Plasmodium berghei yoelii infection in mice.

  1974cited by this paper
• Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.

  1974cited by this paper
• Immunotherapy of coccidioidomycosis.

  1974cited by this paper
• Heterocytolysis by Macrophages Activated by Bacillus Calmette-Gu�rin: Lysosome Exocytosis into Tumor Cells

  1974cited by this paper
• Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

  1974cited by this paper
• EFFECT OF NORMAL AND ACTIVATED HUMAN MACROPHAGES ON TOXOPLASMA GONDII

  1974cited by this paper
• Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.

  1974cited by this paper
• The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.

  1974cited by this paper
• Suppression of Cell-Mediated Immunity in Experimental African Trypanosomiasis

  1974cited by this paper
• Effect of Toxoplasma gondii on the Thymus

  1973cited by this paper
• Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis viruses.

  1973cited by this paper
• THE ENHANCEMENT OF MACROPHAGE BACTERIOSTASIS BY PRODUCTS OF ACTIVATED LYMPHOCYTES

  1973cited by this paper
• Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.

  1973cited by this paper
• Selective cytotoxicity of peritoneal leucocytes for neoplastic cells.

  1973cited by this paper
• Macrophage Nonimmunologic Recognition: Target Cell Factors Related to Contact Inhibition

  1973cited by this paper
• Abnormalities in lymphocyte proliferation in classical and atypical measles infection.

  1973cited by this paper

• PRONADISA : Reactivos de calidad internacional made in Spain

  2009cites this paper
• Chapter 31 – Toxoplasmosis

  2006cites this paper
• Iron in Central Nervous System Disorders

  2001cites this paper
• Mitogen- andAntigen-Specific Proliferation ofT Cells in MurineToxoplasmosis IsInhibited byReactive Nitrogen Intermediates

  2001cites this paper
• Interactions Between Cytokine Induced Nitric Oxide and Intracellular Iron

  1998cites this paper
• Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology

  1995cites this paper
• Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis

  1995cites this paper
• Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates

  1994cites this paper
• Assembly and regulation of NADPH oxidase and nitric oxide synthase.

  1994cites this paper
• Biological Synthesis of Nitric Oxide from L-Arginine

  1994cites this paper
• Cytokine induced synthesis of nitric oxide from L-arginine: a cytotoxic mechanism that targets intracellular iron

  1993cites this paper
• Polyclonal activation of human lymphocytes and induction of cytotoxic lymphocytes by streptococcal preparations

  1992cites this paper
• Mechanism of stimulation of T cells by Streptococcus pyogenes: isolation of a major mitogenic factor, cytoplasmic membrane-associated protein

  1992cites this paper
• 21 – Immunotoxic effects of anticholinesterases

  1992cites this paper
• Activated Macrophage Conditioned Medium: Identification of the Soluble Factors Inducing Cytotoxicity and the L‐Arginine Dependent Effector Mechanism

  1991cites this paper
• The Characterization of Immunotherapeutic Agents

  1990cites this paper
• Immunopharmacology

  1990cites this paper
• Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients

  1989cites this paper
• Efforts towards a vaccine against Toxoplasma gondii: a review.

  1988cites this paper
• Spleen and lymph node cell populations, In vitro cell proliferation and interferon‐y production during the primary immune response to Toxoplasma gondii

  1986cites this paper
• Influence of Toxoplasma on manifestations of Moloney virus infections.

  1985cites this paper
• In Vitro Antiviral Properties of Endotoxin‐Activated Rat Kupffer Cells

  1985cites this paper
• Specific safety problems of inappropriate immune responses to immunostimulating agents

  1985cites this paper
• Immunopharmacologic Regulation of the Mononuclear Phagocyte System

  1985cites this paper
• The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections

  1984cites this paper
• Immunostimulation

  1984cites this paper
• Immune response of mice to ingested Toxoplasma gondii: a model of toxoplasma infection acquired by ingestion.

  1984cites this paper
• Cytostatic and cytolytic activities of macrophages regulation by prostaglandins.

  1984cites this paper
• The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections

  1984cites this paper
• Immunologic lesions during Toxoplasma gondii infection.

  1983cites this paper
• Toxoplasma gondii: decreased resistance to intracellular bacteria in mice.

  1983cites this paper
• Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.

  1983cites this paper
• Toxoplasma gondii: lymphocyte function during acute infection in mice.

  1982cites this paper
• Activation of murine mononuclear phagocytes for destroying tumor cells: analysis of effector mechanisms and development.

  1982cites this paper
• ANALYSIS OF MACROPHAGE ACTIVATION AND BIOLOGICAL RESPONSE MODIFIER EFFECTS BY USE OF OBJECTIVE MARKERS TO CHARACTERIZE THE STAGES OF ACTIVATION

  1982cites this paper
• Natural killer cells induced by acute and chronic toxoplasma infection.

  1982cites this paper
• THE RELATIONSHIP BETWEEN SECRETION OF A NOVEL CYTOLYTIC PROTEASE AND MACROPHAGE-MEDIATED TUMOR CYTOTOXICITY

  1982cites this paper
• Regulation of macrophage accessory functions by interactions involving lymphokines and endotoxin

  1982cites this paper